- Home
- PCOR vs KYMR Comparison
PCOR vs KYMR Comparison
Compare PCOR & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCOR | KYMR |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.7B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PCOR | KYMR |
|---|---|---|
| Price | $57.87 | $108.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 24 | 24 |
| Target Price | $68.52 | ★ $139.35 |
| AVG Volume (30 Days) | ★ 2.9M | 745.2K |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.94 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $1,322,509,000.00 | $39,211,000.00 |
| Revenue This Year | $14.50 | $167.19 |
| Revenue Next Year | $13.30 | N/A |
| P/E Ratio | $1,140.90 | ★ N/A |
| Revenue Growth | ★ 14.83 | N/A |
| 52 Week Low | $38.03 | $55.26 |
| 52 Week High | $82.32 | $130.05 |
Technical Indicators
Market Signals| Indicator | PCOR | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 60.91 | 45.70 |
| Support Level | $53.42 | $100.63 |
| Resistance Level | $59.42 | $119.89 |
| Average True Range (ATR) | 2.04 | 5.35 |
| MACD | 0.69 | -0.19 |
| Stochastic Oscillator | 78.64 | 46.49 |
Price Performance
Historical ComparisonAbout PCOR Procore Technologies Inc.
Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.